Advancing the Future of
Global Medical Aesthetics
"JSBIO is a forward-looking company advancing into the global market in line with the latest trends in the aesthetic industry."
Global Collaboration
We collaborate with strategic partners across Korea, Asia, the Middle East, Europe, and Latin America. Our expertise spans development, marketing, sales, and design of cutting-edge aesthetic medical devices and cosmeceutical products.
Certified Excellence
Our highest priority is meeting customer needs through premium quality. We offer proprietary product lines fully certified with CE, ISO 13485, GMP, and CPNP approvals, ensuring safety and efficacy in every solution.
A Specialized & Reliable Leader
Through continuous growth and global cooperation, JSBIO is evolving into a specialized leader in the aesthetic field, supplying a wide range of industry-related products to professionals worldwide.
Build Your Partnership with JSBIO
Inquire about our distribution opportunities and global aesthetic solutions.
Contact UsOur Journey & Milestones
Global Regulatory Excellence
- PLANNED Nov 2026: Expected CE MDR Certification (Medical Device Regulation).
- LAUNCH Dec 2024: Launched SOSUM X (10ml).
- CERTIFIED Jan 2022: Obtained CE Certification for SOSUM PLUS.
2020 — 2018
Sep 2020: Obtained CE Certification (MDD) for SOSUM S, M, H, Soft, and Hard.
Mar 2020: Launched proprietary cosmetic product SOSUM SAC Solution.
Oct 2019: Signed supply agreement with CHA Meditech for Hyafilia.
Mar 2019: Launched proprietary HA filler line: SOSUM S, M, H.
Oct 2018: Launched SOSUM Stem Cell Activator.
May 2018: Launched proprietary cosmetic brands: CINELAR Plus and SOSUM PCL Solution.
2017 — 2015
Sep 2017: Signed OEM filler brand agreement (Page Lab) with Page Plastic Surgery Clinic.
Jun 2016: Launched proprietary HA filler brand: SOSUM Soft and SOSUM Hard.
Oct 2015: Signed consulting agreement with Yuyoung Pharmaceutical.
2014 — 2011
Oct 2014: Signed supply agreement with Sewon Cellontech for collagen filler Therafill.
Sep 2014: Signed domestic distribution agreement with JW Pharmaceutical for Tissuefill.
Jul 2014: Signed distribution agreement with CHA Meditech for HA booster Tissuefill.
Mar 2013: Signed distribution agreement with CHA Bio F&C for Tissuefill and Hyafilia.
Aug 2011: Founded JSBIO Co.,Inc.




0 Comments